NurExone Biologic Inc (NRX)

Currency in CAD
0.50
-0.02(-3.85%)
Closed·
Advertisement
Earnings results expected in 6 days
NRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.490.53
52 wk Range
0.441.14
Key Statistics
Prev. Close
0.5
Open
0.53
Day's Range
0.49-0.53
52 wk Range
0.44-1.14
Volume
18.7K
Average Volume (3m)
18.16K
1-Year Change
-39.759%
Book Value / Share
0.03
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

NurExone Biologic Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
03/06/2026
EPS / Forecast
-0.02 / -0.05
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare NRX to Peers and Sector

Metrics to compare
NRX
Peers
Sector
Relationship
P/E Ratio
−5.4x−3.5x−0.4x
PEG Ratio
−0.720.060.00
Price/Book
17.3x4.0x2.6x
Price / LTM Sales
-14.1x3.1x
Upside (Analyst Target)
-55.6%46.0%
Fair Value Upside
Unlock−15.7%5.3%Unlock

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.

FAQ

What Is the NurExone Biologic (TSXV: NRX) Share Price Today?

The NurExone Biologic stock price today is 0.50 CAD.

What Stock Exchange Does NurExone Biologic (NRX) Trade On?

NurExone Biologic is listed and trades on the TSX Venture Exchange.

What Is the Ticker (Stock Symbol) for NurExone Biologic?

The stock symbol (also called a 'ticker') for NurExone Biologic is "NRX."

What Is the Current NurExone Biologic Market Capitalisation?

As of today, NurExone Biologic (TSXV: NRX) market cap is 48.20M CAD.

What Is NurExone Biologic's (NRX) Earnings Per Share (TTM)?

The NurExone Biologic EPS is currently -0.08 (Trailing Twelve Months).

When Is the Next NurExone Biologic Earnings Date?

NurExone Biologic's next earnings report will be released on 02/09/2026.

Is NRX a Buy or Sell From a Technical Analyst Perspective?

Based on today's NurExone Biologic moving averages and other technical indicators, the daily buy/sell signal for NRX stock is Sell.

How Many Times Has NurExone Biologic Stock Split?

NurExone Biologic has split 0 times. (See the NRX stock split history page for full effective split date and price information.)

What is the current trading status of NurExone Biologic (TSXV: NRX)?

As of 27/08/2026, NurExone Biologic (NRX) is trading at a share price of 0.50 CAD, with a previous close of 0.50 CAD. The stock has fluctuated within a day range of 0.49 CAD to 0.53 CAD, while its 52-week range spans from 0.44 CAD to 1.14 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.